Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 2
Tick-Borne Encephalitis Virus (TBEV) non-structural protein 2B (NS2B) is a cofactor that plays a crucial role in the viral NS2B/NS3 protease complex, which is essential for viral replication and polyprotein processing. The NS2B protein acts as an indispensable partner to the NS3 protease, enhancing its proteolytic activity necessary for cleaving the viral polyprotein into functional units. This complex is critical for generating mature viral proteins such as C (capsid), prM (precursor membrane protein), and others necessary for the viral life cycle. Mutations and variations in the NS2B region can significantly impact protease function, affecting viral replication efficiency and pathogenicity. Structural studies of the NS2B-NS3 protease have provided insights into its mechanism, guiding the development of inhibitors aimed at disrupting this protease activity to curb viral proliferation. Targeting the NS2B-NS3 interaction represents a promising therapeutic strategy for treating TBEV infections, given the essential role of this protease complex in the viral replication process.
仅用于科研。不用于诊断过程。未经明确授权不得转售。